|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Cardiac Surgery, Policlinico S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti, 9, Bologna 40138, Italy
(Email: dpacini{at}hotmail.com).
Nowadays, antegrade selective cerebral perfusion (ASCP) represents the best method of brain protection during aortic arch surgery, and different strategies are currently in use depending on each individual surgeon's experience. This variety in ASCP methods is due to the fact that the ideal temperature and the optimal flow rate during cerebral perfusion have not yet been definitively established.
Strauch and colleagues [1] have once again made an important contribution to the ever-increasing body of knowledge concerning ASCP. Specifically, in this article, they report their findings with a porcine experimental preparation using ASCP and randomization to either moderate hypothermia (25°C) or mild hypothermia (30°C). The end points measured included cerebral blood flow, cerebral oxygen consumption, and intracranial pressure.
Despite the limitations of the experimental model, the authors have collected important data demonstrating the following:
As is well known, inadequate brain protection results from the imbalance between the supply of cerebral blood flow and cerebral oxygen consumption. This imbalance, as demonstrated by Strauch and colleagues [1], is more evident during prolonged ASCP. In fact, prolonged periods of ASCP cause a progressive reduction of cerebral blood perfusion and an increase in cerebral oxygen consumption, above all at higher temperatures (30°C), and in those areas, such as the pons and cerebellum, which are more sensitive to ischemia.
Similar experimental studies [2, 3] in pigs demonstrated better cerebral protection using deeper systemic hypothermia and a lower temperature of ASCP (15°C to 20°C), but on the other hand there is also increasing evidence that deep hypothermia is associated with direct negative effects on cerebral neuronal integrity [4].
We demonstrated in humans that moderate systemic hypothermia at a nasopharyngeal temperature of 26°C, as compared with lower temperatures of hypothermia (21°C), provides the same clinical results in terms of mortality and morbidity, with particular reference to the neurologic outcomes [5]. This degree of hypothermia may represent an effective compromise, allowing good overall body protection and avoiding the well-known hypothermia-related side effects.
However, further randomized prospective studies are necessary to define the ideal systemic temperature and the optimal flow rate, also keeping in mind that not only the brain but the entire body (the visceral organs, the spinal cord, and so forth) have to be effectively protected.
| References |
|---|
|
|
|---|
Related Article
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |